SCHEMBL26075922

SCHEMBL26075922

Cc1ccc2nc(-c3ccc(-c4ccc(Oc5ccccc5)cc4)c(F)c3)cc(C(=O)O)c2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 9/20 0.66
▸ KDM4E B2RXH2 4/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ MAPT P10636 6/20 0.58
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ LMNA P02545 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ NPC1 O15118 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590279 0.91 DHODH (0.81) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075561 0.87 KDM4E (0.76) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075909 0.87 KDM4E (0.54) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075296 0.87 KDM4E (0.59) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075913 0.87 KDM4E (0.54) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL23590139 0.86 DHODH (0.64) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL27015272 0.85 DHODH (0.57) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075408 0.84 DHODH (0.45) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075954 0.84 DHODH (0.52) DHODHKDM4EALDH1A1HSD17B10MAPT
SCHEMBL26075912 0.84 DHODH (0.52) DHODHKDM4EALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018108-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2024-01-18 — — US disclosed
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885KDM4E 1396/4885ALDH1A1 88/4885
US-20240018108-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DLD, FAH DHODH 1/4885KDM4E 580/4885ALDH1A1 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback